CN1146554C - 非甾体抗雌激素的对映体选择性合成 - Google Patents

非甾体抗雌激素的对映体选择性合成 Download PDF

Info

Publication number
CN1146554C
CN1146554C CNB998119113A CN99811911A CN1146554C CN 1146554 C CN1146554 C CN 1146554C CN B998119113 A CNB998119113 A CN B998119113A CN 99811911 A CN99811911 A CN 99811911A CN 1146554 C CN1146554 C CN 1146554C
Authority
CN
China
Prior art keywords
formula
compound
temperature
ethanol
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998119113A
Other languages
English (en)
Chinese (zh)
Other versions
CN1322200A (zh
Inventor
Rw
R·W·德拉佩尔
�Ү��
R·V·伊耶尔
ض�
Y·卢
E·J·瓦特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1322200A publication Critical patent/CN1322200A/zh
Application granted granted Critical
Publication of CN1146554C publication Critical patent/CN1146554C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CNB998119113A 1998-08-14 1999-08-12 非甾体抗雌激素的对映体选择性合成 Expired - Fee Related CN1146554C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13421698A 1998-08-14 1998-08-14
US09/134,216 1998-08-14
US09/134216 1998-08-14

Publications (2)

Publication Number Publication Date
CN1322200A CN1322200A (zh) 2001-11-14
CN1146554C true CN1146554C (zh) 2004-04-21

Family

ID=22462296

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998119113A Expired - Fee Related CN1146554C (zh) 1998-08-14 1999-08-12 非甾体抗雌激素的对映体选择性合成

Country Status (10)

Country Link
EP (1) EP1104414B1 (enExample)
JP (2) JP3684332B2 (enExample)
CN (1) CN1146554C (enExample)
AT (1) ATE232525T1 (enExample)
AU (1) AU5459399A (enExample)
CA (1) CA2340343C (enExample)
DE (1) DE69905376T2 (enExample)
ES (1) ES2188222T3 (enExample)
WO (1) WO2000009493A1 (enExample)
ZA (1) ZA200100875B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791132A4 (en) 2011-12-14 2015-08-05 Seragon Pharmaceuticals Inc ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
BR112014014767A2 (pt) 2011-12-16 2017-06-13 Olema Pharmaceuticals Inc novos compostos de benzopirano, composições e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
AU8102398A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute (dl)-2,3-diaryl-2h-1-benzopyrans
AU8102498A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute Preparation of diaryl-benzopyrans
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Also Published As

Publication number Publication date
ES2188222T3 (es) 2003-06-16
WO2000009493A1 (en) 2000-02-24
JP2002522533A (ja) 2002-07-23
CN1322200A (zh) 2001-11-14
CA2340343C (en) 2007-04-24
AU5459399A (en) 2000-03-06
JP3684332B2 (ja) 2005-08-17
ATE232525T1 (de) 2003-02-15
JP4461048B2 (ja) 2010-05-12
ZA200100875B (en) 2002-06-26
CA2340343A1 (en) 2000-02-24
DE69905376D1 (de) 2003-03-20
HK1036978A1 (en) 2002-01-25
DE69905376T2 (de) 2003-10-09
JP2005206610A (ja) 2005-08-04
EP1104414A1 (en) 2001-06-06
EP1104414B1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
CN1215045C (zh) 3,3－二苯基丙胺类化合物的新衍生物的稳定盐
CN1053923A (zh) 具有神经保护作用的3-哌啶子基-4-羟基苯并二氯吡喃衍生物
CN100340552C (zh) 芳基醚的制备方法
CN1091636A (zh) 药物
CN1251582A (zh) 经由新中间体不对称合成苯并噁嗪酮类化合物
CN1195759C (zh) 制备苯并噁嗪衍生物及其中间体的方法
CN1191230C (zh) 神经氨酸苷酶抑制剂ro－64－0796的制备方法
CN1225084A (zh) 手性β－氨基酸的不对称合成
CN1050022A (zh) 去氢环黄皮酰胺衍生物的制备方法
CN1095830C (zh) 制备烷氧基亚氨基乙酰胺衍生物的方法
US6262270B1 (en) Enantioselective synthesis
CN1630555A (zh) 应用锆催化剂羟基化β－二羰基化合物的方法
CN1839116A (zh) 不对称脲化合物和通过用其作催化剂的不对称共轭加成反应制备不对称化合物的方法
CN1310171A (zh) 新的三环衍生物和它们的制备方法
CN1026785C (zh) 黄皮酰胺，新黄皮酰胺及其衍生物的制备方法
CN1759097A (zh) 制备用以获得n－甲酰基羟胺的中间体的化学方法
CN1906146A (zh) 环氧基三唑化合物的制备方法及其中间体
CN1254713A (zh) 新的沉香呋喃衍生物,它们的制备方法,含它们的药物组合物及它们作为药物的用途
CN1185208C (zh) 邻氯甲基苯基二羟乙酸衍生物的制备方法
CN1639172A (zh) 用于不对称烯丙基化反应、羟醛反应、串联羟醛反应和烯丙基化反应的试剂
CN1322200A (zh) 对映体选择性合成
CN88102858A (zh) 可用作抗高血压剂的肼衍生物的制备方法
CN1620425A (zh) 制备氨基甲酸2－(取代苯基)－2－羟基－乙酯的方法
CN1496409A (zh) 光学活性的丙氧基苯胺衍生物的制备方法
CN1056487A (zh) 2，2-二甲基-5-(2，5-二甲苯氧基)戊酸的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: MSD CORP.

Free format text: FORMER NAME: SCHERING CORP (US)

CP01 Change in the name or title of a patent holder

Address after: new jersey

Patentee after: Schering Corporation

Address before: new jersey

Patentee before: SCHERING CORP (US)

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040421

Termination date: 20170812